Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Hein

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Pharmacogenetics|August 16, 2001
Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1A J Fretland, M A Doll, M A Leff, et al.
Cancer Research|August 15, 1995
Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutionsD W Hein, M A Doll, T D Rustan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1982
Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strainsD W Hein, T N Smolen, R R Fox, et al.
Analytical Biochemistry|November 1, 1995
Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplificationM A Doll, A J Fretland, A C Deitz, et al.
Psychopharmacology|January 1, 1981
Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeonS Herling, E H Coale, D W Hein, et al.
Toxicology and Applied Pharmacology|February 1, 1997
Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogensA J Fretland, M A Doll, K Gray, et al.
Carcinogenesis|December 1, 1987
Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferaseD W Hein, T J Flammang, W G Kirlin, et al.
Carcinogenesis|March 1, 1996
Effect of acetylator genotype on 3,2'-dimethyl-4-aminobiphenyl induced aberrant crypt foci in the colon of hamstersJ E Paulsen, I L Steffensen, E Namork, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2000
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred ratsM Purewal, M Velasco, A J Fretland, et al.
Cancer Research|February 1, 1993
Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locusD W Hein, M A Doll, K Gray, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Pharmacogenetics|August 16, 2001
Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1A J Fretland, M A Doll, M A Leff, et al.
Cancer Research|August 15, 1995
Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutionsD W Hein, M A Doll, T D Rustan, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1982
Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strainsD W Hein, T N Smolen, R R Fox, et al.
Analytical Biochemistry|November 1, 1995
Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplificationM A Doll, A J Fretland, A C Deitz, et al.
Psychopharmacology|January 1, 1981
Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeonS Herling, E H Coale, D W Hein, et al.
Toxicology and Applied Pharmacology|February 1, 1997
Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogensA J Fretland, M A Doll, K Gray, et al.
Carcinogenesis|December 1, 1987
Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferaseD W Hein, T J Flammang, W G Kirlin, et al.
Carcinogenesis|March 1, 1996
Effect of acetylator genotype on 3,2'-dimethyl-4-aminobiphenyl induced aberrant crypt foci in the colon of hamstersJ E Paulsen, I L Steffensen, E Namork, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2000
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred ratsM Purewal, M Velasco, A J Fretland, et al.
Cancer Research|February 1, 1993
Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locusD W Hein, M A Doll, K Gray, et al.
Pageof 11